Skip to content

Clinical trials

Recruiting Immunoglobulin Light-chain Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Status: Recruiting Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20092
20111
20161
20232
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic2
UNC Lineberger Comprehensive Cancer Center2
Alexion Pharmaceuticals, Inc.1
Boston Medical Center1
Brigham and Women's Hospital1
Dana-Farber Cancer Institute1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Ohio State University Comprehensive Cancer Center1
Rajshekhar Chakraborty, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis16
Multiple Myeloma6
Amyloidosis5
Blast Crisis2
Burkitt Lymphoma2
Congenital Abnormalities2
Hodgkin Disease2
Immunoblastic Lymphadenopathy2
Intraocular Lymphoma2
Leukemia2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.